These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 12759258)

  • 1. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation.
    Capozza F; Williams TM; Schubert W; McClain S; Bouzahzah B; Sotgia F; Lisanti MP
    Am J Pathol; 2003 Jun; 162(6):2029-39. PubMed ID: 12759258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
    Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 deficiency stimulates neointima formation during vascular injury.
    Hassan GS; Jasmin JF; Schubert W; Frank PG; Lisanti MP
    Biochemistry; 2004 Jul; 43(26):8312-21. PubMed ID: 15222744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
    Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
    Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.
    Williams TM; Cheung MW; Park DS; Razani B; Cohen AW; Muller WJ; Di Vizio D; Chopra NG; Pestell RG; Lisanti MP
    Mol Biol Cell; 2003 Mar; 14(3):1027-42. PubMed ID: 12631721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts.
    Cohen AW; Park DS; Woodman SE; Williams TM; Chandra M; Shirani J; Pereira de Souza A; Kitsis RN; Russell RG; Weiss LM; Tang B; Jelicks LA; Factor SM; Shtutin V; Tanowitz HB; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Feb; 284(2):C457-74. PubMed ID: 12388077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.
    Williams TM; Sotgia F; Lee H; Hassan G; Di Vizio D; Bonuccelli G; Capozza F; Mercier I; Rui H; Pestell RG; Lisanti MP
    Am J Pathol; 2006 Nov; 169(5):1784-801. PubMed ID: 17071600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
    Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
    Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
    Woodman SE; Park DS; Cohen AW; Cheung MW; Chandra M; Shirani J; Tang B; Jelicks LA; Kitsis RN; Christ GJ; Factor SM; Tanowitz HB; Lisanti MP
    J Biol Chem; 2002 Oct; 277(41):38988-97. PubMed ID: 12138167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.
    Park DS; Lee H; Frank PG; Razani B; Nguyen AV; Parlow AF; Russell RG; Hulit J; Pestell RG; Lisanti MP
    Mol Biol Cell; 2002 Oct; 13(10):3416-30. PubMed ID: 12388746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 null (-/-) mice show dramatic reductions in life span.
    Park DS; Cohen AW; Frank PG; Razani B; Lee H; Williams TM; Chandra M; Shirani J; De Souza AP; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Biochemistry; 2003 Dec; 42(51):15124-31. PubMed ID: 14690422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.
    Razani B; Engelman JA; Wang XB; Schubert W; Zhang XL; Marks CB; Macaluso F; Russell RG; Li M; Pestell RG; Di Vizio D; Hou H; Kneitz B; Lagaud G; Christ GJ; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Oct; 276(41):38121-38. PubMed ID: 11457855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
    Jasmin JF; Mercier I; Hnasko R; Cheung MW; Tanowitz HB; Dupuis J; Lisanti MP
    Cardiovasc Res; 2004 Sep; 63(4):747-55. PubMed ID: 15306231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
    Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
    J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of Akt signaling in mouse skin tumorigenesis.
    Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
    Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.
    Woodman SE; Ashton AW; Schubert W; Lee H; Williams TM; Medina FA; Wyckoff JB; Combs TP; Lisanti MP
    Am J Pathol; 2003 Jun; 162(6):2059-68. PubMed ID: 12759260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
    Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.